TODD ASSET MANAGEMENT LLC

Position in NVS — Novartis AG

CIK 1071483 Louisville, KY

Position in NVS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$49,747,472

-$16,241,597 QoQ

Shares Held

317,429

-26.5% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.89%

of 13F equity value

Holder Rank

#60

of 1,603 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 36% Shared 0% None 64%

Healthcare · as of Jun 30, 2026

TODD ASSET MANAGEMENT LLC holds $250,852,520 across 11 Drug Manufacturers - General names. NVS ranks #3 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	282,442	$71,073,704
2	GILD	Gilead Sciences, Inc.	421,984	$53,313,458
3	NVS	Novartis AG This page	317,429	$49,747,472
4	AMGN	Amgen Inc	108,134	$39,157,483
5	SNY	Sanofi	674,143	$28,758,939
6	NVO	Novo Nordisk A S	134,460	$6,446,012
7	JNJ	Johnson & Johnson	3,288	$835,053
8	PFE	Pfizer Inc	27,801	$669,448

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,747,472	317,429	-26.5%	Shares	Defined	2026-08-04
2026-03-31	$65,989,069	432,007	-0.5%	Shares	Defined	2026-05-12
2025-12-31	$59,869,495	434,246	-1.3%	Shares	Defined	2026-02-09
2025-09-30	$56,410,082	439,879	+5.8%	Shares	Sole	2025-11-07
2025-06-30	$50,328,179	415,901	+4.9%	Shares	Defined	2025-08-13
2025-03-31	$44,202,934	396,510	+1.4%	Shares	Sole	2025-05-12
2024-12-31	$38,065,822	391,181	-0.8%	Shares	Sole	2025-02-04
2024-09-30	$45,356,756	394,338	-0.6%	Shares	Defined	2024-11-13
2024-06-30	$42,233,852	396,711	+33.9%	Shares	Sole	2024-08-14
2024-03-31	$28,655,875	296,246	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.